Impact of Subsidies and Socioeconomic Status on Varicella Vaccination in Greater Tokyo, Japan by Kei Nagaoka & Takeo Fujiwara
March 2016 | Volume 4 | Article 191
Original research
published: 15 March 2016
doi: 10.3389/fped.2016.00019
Frontiers in Pediatrics | www.frontiersin.org
Edited by: 
Lily Rundjan, 
University of Indonesia, Indonesia
Reviewed by: 
Cihad Dundar, 
Ondokuz Mayis University, Turkey 
Ichiro Morioka, 
Kobe University Graduate School of 
Medicine, Japan 
Brian D.W. Chow, 
Marshfield Clinic, USA
*Correspondence:
Takeo Fujiwara  
fujiwara-tk@ncchd.go.jp
Specialty section: 
This article was submitted to 
Pediatric Infectious Diseases, 
a section of the journal 
Frontiers in Pediatrics
Received: 07 December 2015
Accepted: 29 February 2016
Published: 15 March 2016
Citation: 
Nagaoka K and Fujiwara T (2016) 
Impact of Subsidies and 
Socioeconomic Status on Varicella 
Vaccination in Greater Tokyo, Japan. 
Front. Pediatr. 4:19. 
doi: 10.3389/fped.2016.00019
impact of subsidies and 
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Vaccination in greater Tokyo, Japan
Kei Nagaoka and Takeo Fujiwara*
Department of Social Medicine, National Research Institute for Child Health and Development, Tokyo, Japan
Background: Although the control of varicella outbreaks is an important health issue, 
cost could present a major barrier for vaccination. The aim of this study is to investigate 
the association of vaccine subsidies and caregivers’ socioeconomic status with varicella 
vaccine coverage of their children in Greater Tokyo, Japan, before the period that vari-
cella vaccination was included in routine immunization program.
Methods: Participants were recruited from two different cities. In Chiba city, parents 
of 18-month-old infants (N  =  378) undergoing a medical examination in July 2013 
were recruited at a clinic where no subsidy for varicella immunization was provided. In 
Nishitokyo city, parents of 24- to 30-month-old children (N = 315) undergoing a health 
checkup in July and August 2013 were recruited at a clinic where a partial subsidy was 
provided. The association between household income and varicella immunization was 
investigated by multivariate logistic regression stratified by city.
results: Vaccine coverage was 61.0% in Chiba city and 73.3% in Nishitokyo city. In 
Chiba city, odds ratios of middle and high household income for varicella immunization 
were 4.22 [95% confidence interval (CI): 1.65–10.7] and 5.94 (95% CI: 1.89–18.6), 
respectively, compared to low household income. However, household income was 
not associated with varicella vaccination in Nishitokyo city. Neither working status nor 
education was associated with vaccination in both cities.
conclusion: While household income was associated with high vaccine coverage in 
the city with no vaccine subsidy, this association was not observed in the city where the 
subsidy was given, which suggests that cost is a barrier for varicella immunization. Thus, 
in countries where varicella vaccination is not included in routine immunization programs, 
introducing subsidies nationwide or routine immunization programs for varicella vaccina-
tion would be an important approach to eliminate inequality in vaccine coverage.
Keywords: varicella vaccine, vaccine subsidy, varicella, socioeconomic status
inTrODUcTiOn
Varicella is a common, highly infectious disease caused by the varicella-zoster virus that mainly 
affects young children. Although the natural course of the disease is self-limiting, it lasts 4–5 days 
(1). Until the rash disappears, affected children are not allowed to go to nursery, kindergarten, 
and school, and parents need to stay at home to take care of them, which increases the social cost 
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of varicella infection. An estimated one million children are 
diagnosed with varicella each year in Japan, and of this number 
at least 4,000 children require admission to hospital. Although 
deaths are rare, varicella can be fatal, especially in neonates and 
immunocompromised individuals; 20 patients have died due to 
complications of varicella in Japan (2). Needless to say, medical 
costs associated with varicella infection are a huge burden. The 
total annual cost associated with varicella is estimated to be JPY 
52.2 billion (3). Antiviral drugs are effective for shortening the 
duration of the disease (4) and are used in many cases in Japan, 
even though the patients have no risk of being severe cases, which 
induces higher cost.
To avoid these burdens, varicella vaccination was included as 
part of routine immunization programs in October 2014. Before 
this inclusion, children in Japan only received varicella vaccina-
tion if their caregivers elected to do so; however, their caregivers 
must cover the cost of the vaccination (approximately 100 USD). 
According to the best available data, varicella vaccination cover-
age was estimated to be as low as 30% (5), suggesting that cost 
was a possible barrier for varicella vaccination. The impact of 
immunization cost may exist in addition to previously reported 
risk factors, including poverty (6–9), single parenthood (6, 8, 
9), ethnic minorities (8, 10–12), young maternal age (<30 years 
old), maternal working status, subsequent child, interaction with 
other children, lack of knowledge on vaccination, a high concern 
about adverse effects of vaccination (13), or living in the inner 
city (14). Thus, it is important to show the direct effect of vaccina-
tion subsidies on varicella vaccination for other countries where 
varicella vaccination is not included in routine immunization 
program, and people have to rely on subsidies to get vaccinated 
against varicella.
In Japan, before the introduction of varicella routine immu-
nization program, some local municipalities offered subsidies 
for varicella vaccination to caregivers, which provided a valuable 
opportunity to investigate the impact of subsidies on varicella 
vaccination. Furthermore, we can assess the impact of the 
vaccine subsidy on varicella vaccination in conjunction with 
socioeconomic status of the household (e.g., household income or 
education). A previous study showed a slight increase in varicella 
vaccine coverage after the introduction of a partial subsidy in two 
cities in Japan (15). However, the study was conducted in rural 
cities where the vaccine coverage was lower than urban cities, 
and it did not investigate the impact of socioeconomic status on 
vaccine coverage.
Thus, the aim of this study is to elucidate the impact of a vac-
cine subsidy and caregivers’ socioeconomic status on varicella 
vaccination.
MaTerials anD MeThODs
Participants were recruited from two cities: 571 parents who 
attended medical examinations for their 18-month-old infants in 
Chiba city in July 2013 were recruited at a clinic with no subsidy 
for varicella immunization, and 342 parents who attended health 
consultations for their 24- to 30-month-old children in Nishitokyo 
city in July and September 2013 were recruited at a clinic with a 
partial subsidy. In both cities, all mothers who attended the event 
were recruited to answer a questionnaire. It cost JPY 5,000–10,000 
(almost 50–100 USD) to vaccinate their child depending on the 
clinic in Chiba city, whereas it cost JPY 4,000 (almost 40 USD) 
in Nishitokyo city. Both Chiba and Nishitokyo cities are districts 
within Greater Tokyo. In August 2013, the population in Chiba 
and Nishitokyo cities was 963,985 and 197,703, respectively. The 
number of 1-year-old children in Chiba and Nishitokyo cities 
was 8,257 and 1,777, respectively. Our study was approved by the 
ethics committee of the National Center for Child Health and 
Development (No. 668), which determined it was unnecessary 
to obtain consent from participants given that responding to the 
anonymous questionnaire already implied consent to participate 
in the study.
We prepared a questionnaire that asked participants whether 
they vaccinated their children, the reasons for not vaccinat-
ing their children, as well as questions on demographics and 
socioeconomic status (parental education and annual household 
income).
We employed a multiple logistic regression model to deter-
mine the odds ratio (OR) of socioeconomic status for varicella 
immunization, stratified by cities. Furthermore, the interaction 
effect between the city and the household income on vaccination 
was also estimated. We used STATA SE statistical package, version 
11 (StataCorp., College Station, TX, USA) for statistical analysis.
resUlTs
Descriptive statistics
In July 2013, 571 children aged 18 months were living in Chiba 
city. Of this number, 535 (93.7%) attended medical examinations 
with a parent and 378 (66.2%) parents completed the question-
naires. In July and August 2013, 342 children aged between 24 
and 30 months attended health consultations with a parent. Of 
this number, 315 (92.1%) parents completed the questionnaires. 
Demographics and socioeconomic status for Chiba and Nishitokyo 
cities are shown in Table 1. The proportion of parents with more 
than two children was higher in Chiba city than Nishitokyo city 
(13.3 vs. 6.2%, p < 0.001). Although the age of children was older 
in Nishitokyo city than Chiba city by 6 months or more, parents’ 
socioeconomic status was almost similar in both cities. However, 
one slight difference in socioeconomic status was found: more 
parents in Chiba city had full-time jobs than those in Nishitokyo 
city (27.4 vs. 17.7%, p = 0.007), and fewer parents in Chiba city 
had an undergraduate degree compared to Nishitokyo city (36.4 
vs. 49.4%, p < 0.001). The proportion of parents whose annual 
household income was lower than JPY two million was slightly 
higher in Chiba city than in Nishitokyo city, although the dif-
ference was not statistically significant (3.8 vs. 1.4%, p = 0.062).
Varicella Vaccine coverage
Varicella vaccine coverage in Chiba and Nishitokyo cities was 61.0 
and 73.3%, respectively (Table 2). Coverage increased to 65.6% in 
Chiba city and 78.5% in Nishitokyo city when we excluded those 
children who were not vaccinated due to a past varicella infec-
tion or other medical reasons. We employed the latter coverage 
as dependent variables.
TaBle 2 | Varicella vaccine coverage rate.
chiba city nishitokyo city
Coverage rate 227/372 (61.0%) 230/314 (73.3%)
Coverage rate (children not immunized due 
to previous varicella infection excluded)
227/346 (65.6%) 230/293 (78.5%)
TaBle 1 | Demographics of chiba and nishitokyo cities.
chiba city 
(N = 372)
nishitokyo city 
(N = 314)
p-Value
Age of the caregiver 33.1 ± 4.8 (21–46) 34.1 ± 4.5 (21–46) 0.009
Sex (F/M ratio) 1.04 0.87 0.26
Birth weight (g) 3,012 ± 444 
(485–4,206)
2,984 ± 405 
(1,214–4,006)
0.40
Gestational age (weeks) 38.6 ± 1.8 (27–41) 38.7 ± 2.2 (28–42) 0.91
Birth order 0.005
First 177 (50%) 165 (53.9%)
Second 130 (36.7%) 122 (39.9%)
Third 44 (12.4%) 13 (4.3%)
>Fourth 3 (0.9%) 6 (1.9%)
Past history
Febrile seizure 19 (5.0%) 17 (5.4%) 0.83
Food allergy 48 (12.7%) 37 (11.8%) 0.70
Atopic dermatitis 25 (6.6%) 11 (3.5%) 0.065
Bronchial asthma 19 (5.0%) 8 (2.5%) 0.092
Others 17 (4.5%) 11 (3.5%) 0.50
No conditions 242 (64.0%) 215 (68.3%) 0.24
Measles vaccine 
coverage
341 (97.4%) 286 (97.3%) 0.91
Number of family 
members
3.7 ± 0.9 (2–7) 3.7 ± 0.9 (2–8) 0.77
Working status 0.012
Full time 97 (27.4%) 54 (17.7%)
Part time 40 (11.3%) 39 (12.8%)
Not working 217 (61.3%) 213 (69.6%)
Education 0.022
Junior high school 10 (2.8%) 6 (2.0%)
High school 69 (19.6%) 52 (17.1%)
Junior college 75 (21.3%) 53 (17.4%)
Vocational college 67 (19.0%) 43 (14.1%)
University 115 (32.7%) 140 (46.1%)
Graduate school 13 (3.7%) 10 (3.3%)
Annual household 
income (JPY)
0.30
Less than 2 million 13 (3.8%) 4 (1.4%)
2–4 million 63 (18.2%) 61 (20.8%)
4–6 million 98 (28.3%) 89 (30.4%)
6–8 million 82 (23.7%) 67 (22.9%)
8–10 million 38 (11.0%) 40 (13.7%)
More than 10 million 29 (8.4%) 17 (5.8%)
Do not wish to answer 23 (6.7%) 15 (5.1%)
TaBle 3 | Univariate analysis of association between varicella 
vaccination and variables of participants.
chiba city Or 
(95% ci)
nishitokyo city 
Or (95% ci)
Age of caregivers (compared to 20s)
30s 3.57 (2.06–6.21) 2.11 (1.01–4.41)
40s 6.92 (2.40–20.0) 2.62 (0.92–7.41)
Female (compared to male) 0.84 (0.53–1.33) 1.14 (0.65–2.01)
Birth weight <2,500 g 0.81 (0.38–1.72) 1.16 (0.42–3.22)
Period of gestation <37 weeks 2.05 (0.67–6.26) 0.67 (0.26–1.68)
Birth order (as one child increases) 0.54 (0.39–0.74) 0.79 (0.54–1.15)
Past history
Febrile seizure 0.96 (0.35–2.66) 0.58 (0.19–1.74)
Food allergy 1.39 (0.70–2.75) 4.93 (1.15–21.2)
Atopic dermatitis 0.29 (0.12–0.68) 1.10 (0.23–5.31)
Bronchial asthma 0.64 (0.25–1.67) 1.95 (0.23–16.1)
Number of family members (as one 
increases)
0.68 (0.53–0.87) 0.72 (0.54–0.98)
Working status (compared to not 
working)
Part time 0.63 (0.31–1.28) 1.08 (0.44–2.64)
Full time 2.14 (1.21–3.78) 0.91 (0.43–1.94)
Education (compared to junior high and 
high schools)
Junior and vocational colleges 1.64 (0.91–2.95) 2.03 (0.96–4.27)
University and graduate school 3.75 (1.97–7.15) 3.02 (1.48–6.14)
Annual household income (compared to 
less than JPY 4 million)
JPY 4–6 million 1.73 (0.92–3.27) 1.05 (0.51–2.16)
JPY 6–8 million 4.96 (2.34–10.5) 1.90 (0.81–4.47)
JPY more than 8 million 6.36 (2.79–14.5) 4.02 (1.37–11.7)
Do not wish to answer 2.64 (0.97–7.23) 2.51 (0.51–12.4)
OR, odds ratio; CI, confidence interval.
Bolds signifies p < 0.05.
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association between socioeconomic 
status and Varicella Vaccination
The association between socioeconomic status and varicella vac-
cination is shown in Table 3. In our bivariate model, education 
and household income in Chiba city were positively associated 
with varicella vaccination. Similarly, in Nishitokyo city, education 
and household income were positively associated with varicella 
vaccination, but the magnitude was lesser.
Multivariate analysis showed that household income remained 
significantly positively associated with varicella vaccination in 
Chiba city (Table 4). Children from a household with an income 
of JPY eight million or more were 6.55 [95% confidence interval 
(CI): 2.14–20.1] times more likely to receive varicella vaccination 
than children from a household income of less than JPY four 
million. However, in Nishitokyo city, household income was not 
associated with varicella vaccination in the multivariate analysis. 
No association between education and vaccine coverage was 
observed in either city. The p-value for interaction term between 
household income and city was 0.124, which might suggest that 
the subsidy was helpful in increasing vaccine coverage.
reasons for not Vaccinating Their 
children
We further asked the parents, who did not vaccinate their chil-
dren, for the reason why they did not do so (Table 5). Few parents 
knew about the varicella vaccine (6.2 and 16.7% in Chiba and 
Nishitokyo cities, respectively), and 30.3% of parents in Chiba 
city regarded vaccine cost as a barrier compared to 11.9% in 
Nishitokyo city.
DiscUssiOn
impact of subsidy on Varicella Vaccination
This study showed that household income was positively associ-
ated with varicella vaccine in an urban city where no vaccine 
TaBle 5 | reasons for parents not vaccinating children for varicella.
chiba city 
(N = 145)
nishitokyo city 
(N = 84)
Planning to vaccinate in future 25 (17.2%) 4 (4.8%)
Children are not expected to be vaccinated 
due to
26 (18.0%) 21 (25.0%)
Previous infection of varicella 24 (16.6%) 21 (25.0%)
Other medical conditions (such as post gamma-
globulin therapy)
2 (1.4%) 0 (0%)
Have little knowledge on vaccines 9 (6.2%) 14 (16.7%)
Do not consider varicella to be a serious disease 4 (2.8%) 7 (8.3%)
Afraid of side effects of varicella vaccine 4 (2.8%) 6 (7.1%)
Consider varicella vaccine to be ineffective 2 (1.4%) 5 (6.0%)
Agree that there are barriers to vaccination 87 (60.0%) 33 (39.3%)
Cost of vaccines is too expensive 44 (30.3%) 10 (11.9%)
Have no time to take children for vaccinations 22 (15.2%) 9 (10.7%)
There are too many other vaccines 47 (32.4%) 20 (23.8%)
Effect of surroundings 19 (13.1%) 11 (13.1%)
Family doctors did not recommend the vaccine 15 (10.3%) 8 (9.5%)
Neighbors did not vaccinate their children either 6 (4.1%) 3 (3.6%)
Articles read on the internet advised not to 
vaccinate children
1 (0.7%) 0 (0%)
Other 6 (4.1%) 14 (16.7%)
TaBle 4 | Multivariate analysis of association between varicella 
vaccination and variables of participants.
chiba city Or 
(95% ci)
nishitokyo city 
Or (95% ci)
Age of caregivers (compared to 20s)
30s 3.17 (1.56–6.43) 1.77 (0.70–4.49)
40s 4.65 (1.38–15.7) 2.67 (0.69–10.4)
Female (compared to male) 0.84 (0.46–1.52) 1.13 (0.59–2.19)
Birth weight <2,500 g 0.31 (0.10–0.94) 1.91 (0.55–6.59)
Period of gestation <37 weeks 3.91 (0.73–21.1) 0.45 (0.14–1.41)
Past history
Febrile seizure 0.93 (0.26–3.37) 0.61 (0.16–2.38)
Food allergy 2.54 (0.91–7.09) 3.56 (0.76–16.6)
Atopic dermatitis 0.08 (0.02–0.26) 1.13 (0.17–7.29)
Bronchial asthma 0.90 (0.24–3.44) 1.34 (0.14–12.8)
Number of family members (as one 
increases)
0.55 (0.39–0.77) 0.70 (0.49–1.01)
Working status (compared to not 
working)
Part time 1.05 (0.44–2.55) 1.65 (0.53–5.14)
Full time 2.12 (0.96–4.67) 1.20 (0.46–3.09)
Education (compared to junior high and 
high schools)
Junior and vocational colleges 1.05 (0.49–2.25) 1.31 (0.52–3.30)
University and graduate school 1.96 (0.83–4.67) 2.02 (0.81–5.06)
Annual household income (compared to 
less than JPY 4 million)
JPY 4–6 million 1.89 (0.88–4.05) 1.03 (0.45–2.37)
JPY 6–8 million 4.32 (1.71–10.9) 1.42 (0.50–4.01)
More than JPY 8 million 6.55 (2.14–20.1) 2.98 (0.88–10.1)
Do not wish to answer 4.27 (1.11–16.4) 2.18 (0.39–12.1)
OR, odds ratio; CI, confidence interval.
Bolds signifies p < 0.05.
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subsidy was provided. This supports previous research that 
showed poverty to be a risk factor for underimmunization (6–9). 
Furthermore, the current study demonstrated the positive impact 
of the subsidy for varicella vaccination. This finding is consist-
ent with a previous study that reported an increase in vaccine 
coverage from 8.0 to 17.2% in one rural city and 13.0 to 27.9% in 
another, after the introduction of a vaccine subsidy in 2007 (15).
The positive association observed between household income 
and vaccination in Chiba city (no subsidy) and the lack of such 
an association in Nishitokyo (partial subsidy) suggests that the 
subsidy was helpful in boosting vaccine coverage, regardless 
of household income. Moreover, about one-third of parents 
who did not vaccinate their children reported cost as a reason 
for not vaccinating in Chiba city (no subsidy), whereas only 
one-tenth of parents regarded cost as a barrier to vaccination in 
Nishitokyo (partial subsidy). Unlike a previous study conducted 
by Matsumura et  al. in Japan (13), parents’ low knowledge on 
vaccination and concerns about possible adverse effects were not 
the major reasons for not vaccinating their children. One possible 
reason is the difference between vaccines in the two studies. The 
study by Matsumura et al. focused on the free measles-containing 
vaccine, whereas the present study focused on the varicella vac-
cine, which is not free. This might imply that a few parents might 
not vaccinate their children for varicella, even after the introduc-
tion of a complete subsidy. To address this issue, better promotion 
of the vaccine and building knowledge on varicella vaccination is 
still needed, even after introduction of the subsidy.
Factors other than socioeconomic ones were also associated 
with low vaccine coverage in multivariate analysis in Chiba 
city. These factors included younger age of caregivers, low birth 
weight, history of atopic dermatitis, and large number of family 
members. A previous study conducted in Japan also showed that 
the characteristics related to uncompleted measles vaccination 
were mother’s younger age and being a subsequent child (13). 
Little is known about the association of history of children with 
vaccine coverage in Japan, including low birth weight. The sched-
ule of vaccine for children with low birth weight might be delayed 
because of long-term hospital stay and infection during infancy 
due to their vulnerability. Caregivers of children with atopic 
dermatitis might have concerns over drug allergies, which may 
be associated with caregiver’s reluctance in having their children 
vaccinated.
Vaccine coverage
The coverage of varicella vaccination in our study was 61.0% for 
infants aged 18 months in Chiba where no subsidy was provided, 
although a previous study showed that coverage of preschool 
children was around 30% (5). The reason for higher coverage 
in our study might be because our study setting comprised two 
clinics in urban areas of Greater Tokyo, where vaccine coverage is 
generally higher compared to rural areas of Japan. Although the 
Japanese government has promoted vaccines that are included 
in routine immunization programs, promotion of other vaccines 
depends on the local government. Therefore, urban cities with a 
bigger budget and a greater number of staff can disseminate those 
vaccines more easily, and this point might have contributed to the 
high vaccine coverage in our study.
limitations
First, our study did not directly show any changes in vaccine cov-
erage caused by the introduction of the subsidy. However, Chiba 
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and Nishitokyo cities are both commuting distance from Tokyo, 
and residents from both cities have common characteristics in 
terms of socioeconomic status. Thus, the difference in vaccine 
coverage is mainly attributable to the subsidy.
Second, our study could not examine the effect of the 
complete subsidy for the varicella vaccine. However, our 
study revealed the possibility that only a partial subsidy might 
improve vaccine coverage, which suggests that a complete 
subsidy would further improve vaccine coverage. Third, the 
method to recruit participants in the two cities and the age of 
children were different, which may affect the differential impact 
on the association between socioeconomic status and varicella 
vaccination. Further study is needed to investigate the impact of 
subsidy on vaccination, comparing the vaccination rate before 
and after introduction of subsidy, using children of the same age 
in the same city.
Political implications
Varicella vaccination is shown to be cost-effective in many stud-
ies (16), including a previous Japanese study (3) and the current 
study. Therefore, increasing vaccine coverage eventually reduces 
overall costs to the government, even if the government pays all 
costs of the vaccine. Moreover, subsidies for vaccination should be 
encouraged in order to remedy health inequality among children 
in countries where varicella vaccination is not included in routine 
immunization programs, which has received large attention in 
previous studies (17, 18). Children from households with a low 
income tend to have poorer health and achieve less academically, 
which reduces opportunities for a good job in future and, hence, 
less income. Therefore, subsidies for vaccines would also be help-
ful in tackling this cycle. Although subsidy is thought to be effec-
tive for boosting vaccine coverage, subsidy alone is not adequate 
because only half of the parents in Chiba city who answered the 
questionnaire stated that cost was a barrier for vaccination. To 
achieve desirable varicella vaccine coverage, not only monetary 
support but also the spread of correct knowledge on vaccine is 
important. Therefore, inclusion of varicella vaccine in national 
routine immunization program is essential.
cOnclUsiOn
Varicella vaccine coverage of children aged 18 months was 61.0% 
in Chiba city where no subsidy was provided, whereas cover-
age of children aged 24–30  months was 73.3% in Nishitokyo. 
Multivariate analysis showed that household income was posi-
tively associated with varicella vaccination in Chiba city, while no 
association between household income and varicella vaccination 
was found in Nishitokyo city. These findings suggest that vaccine 
subsidy may be useful for children in low-income families. Thus, 
in countries where varicella vaccination is not included in routine 
immunization programs, introducing subsidies nationwide or 
routine immunization programs for varicella vaccination would 
be an important approach to eliminate inequality in vaccine 
coverage.
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